{"schema_version": 1, "id": "durham-nc-msa/life-sciences/2026-09", "product": "Labor Market Pulse", "metro": {"geography_id": 130, "label": "Durham, NC MSA", "slug": "durham-nc-msa"}, "focus_area": {"key": "life_sciences", "slug": "life-sciences", "label": "Life Sciences"}, "period": "2026-09", "public_after": "2026-09-01", "frozen_at": "2026-10-09T13:20:24.226766+00:00", "headline": "Durham's biomanufacturing boom collides with a shrinking labor pool.", "headline_summary": "Regulatory Affairs Specialist pay jumped to a $119,275 metro median while Durham-Chapel Hill unemployment sits at 3.4%, as Amgen and J&J add 790 jobs into a labor force that contracted nearly 70,000 statewide over the year.", "key_indicators": [{"label": "Durham-Chapel Hill unemployment", "value": "3.4%", "context": "vs 4.1% national, Feb 2026 reading"}, {"label": "NC labor force change (YoY)", "value": "-70,000", "context": "Statewide contraction despite job growth"}, {"label": "Life sci capital investment, NC", "value": "$3B", "context": "Amgen + J&J, ~790 new jobs combined"}, {"label": "Regulatory Affairs Specialist pay", "value": "$119,275 metro median", "context": "vs flat $104,000 national median"}], "takeaways": [{"headline": "Regulatory Affairs pay is pulling away from the national trend.", "body": "Metro median advertised pay for Regulatory Affairs Specialist rose to $119,275 while the national figure held flat near $104,000, a divergence consistent with acute local scarcity rather than a broad national repricing. Compensation benchmarking for this role should weight Durham-specific movement over national averages this cycle."}, {"headline": "Biostatistician and Clinical Data Manager pay are falling locally while diverging nationally.", "body": "Biostatistician metro median dropped significantly to $148,588 even as the national median rose to $133,322, and Clinical Data Manager fell locally while declining more modestly nationally. This may reflect softer local posting volume for these roles rather than actual demand erosion \u2014 worth confirming before assuming reduced need for data science capacity."}, {"headline": "Entry-level manufacturing pipeline is maturing faster than the specialized talent pipeline.", "body": "Wilson County's BioWork credential program is placing graduates into J&J and Fresenius Kabi roles at $67,000 starting pay, demonstrating a working model for operator-level hiring. Scientific, quality, and regulatory talent has no comparable regional pipeline, pointing toward build-vs-outsource tradeoffs concentrating at the specialized end, not entry-level manufacturing."}, {"headline": "A tightening labor force is colliding with a wave of capital investment.", "body": "North Carolina's labor force contracted nearly 70,000 over the year even as Amgen and J&J commit a combined $3B and roughly 790 jobs to the region. Headcount planning across R&D, clinical, and manufacturing functions should account for slower natural replenishment of the regional talent pool, not just competitive hiring."}], "local_conditions": "Durham-Chapel Hill's 3.4% unemployment rate continues to run well below the 4.1% national figure, even as North Carolina's labor force shrinks year-over-year and statewide wage growth decelerates to roughly 4% from a 2022 peak above 6%. Fresh capital commitments \u2014 Amgen's $1B Holly Springs expansion and J&J's $2B Wilson County biologics campus, together representing nearly 800 new jobs \u2014 are landing in a metro where healthcare practitioner and computer/math occupations already outpace national employment share, intensifying competition for a labor pool that isn't growing to match.", "implications": "Expansion announcements from Amgen and J&J signal durable, capital-backed demand for biomanufacturing talent, but the BioWork pipeline out of Wilson Community College addresses operator-level roles, not the specialized scientific, quality, and regulatory talent these facilities also require \u2014 leaving senior and credential-driven roles exposed to a genuinely tight regional supply. Regulatory Affairs Specialist advertised pay climbing to a $119,275 metro median against a flat $104,000 national figure suggests Durham employers are bidding up scarce compliance expertise specifically, a pattern that should inform whether open regulatory and quality headcount gets filled locally or absorbed through CRO/CDMO partners. Organizations should evaluate whether current headcount plans for regulatory, quality, and specialized manufacturing roles assume a local talent supply that recent capital investment is actively straining.", "looking_ahead": [{"category": "Worth watching", "body": "NC Life Sciences Organization's Q3 forum directly questioned whether the state's biomanufacturing workforce can meet demand from Amgen, J&J, and other recent expansions. Outcomes from that discussion may shape whether employers lean harder on CDMO capacity or accelerate internal training investment."}, {"category": "Emerging pressure point", "body": "Clinical Research Associate pay rose significantly both locally ($94,445) and nationally ($90,956), a rare case of aligned local and national tightness. Watch whether this signals broader clinical operations staffing pressure spreading beyond Durham's biomanufacturing-heavy profile."}, {"category": "Potential inflection point", "body": "Healthcare WARN notices accounted for 1,455 affected workers statewide in 2026, the third-largest category after manufacturing and transportation. Monitor whether any Durham-area clinical or healthcare separations release regulatory, quality, or clinical operations talent into the local candidate pool."}, {"category": "Early indicator", "body": "Raleigh-Cary's 3.1% unemployment rate, tighter than the state's 3.6%, suggests Research Triangle-wide competition for talent extends beyond Durham proper. Compensation strategy should account for Raleigh-Durham as a single competitive labor shed rather than separate markets."}], "roles": [{"role": "Research Scientist", "data_scope": "metro", "metro_p25": 71354.25, "metro_p50": 110164.0, "metro_p75": 126981.5, "metro_trend_direction": "down", "metro_trend_magnitude": "moderate", "national_p50": 131354.0, "national_trend_direction": "up", "national_trend_magnitude": "significant"}, {"role": "Clinical Research Associate", "data_scope": "metro", "metro_p25": 61940.25, "metro_p50": 94445.0, "metro_p75": 119000.0, "metro_trend_direction": "up", "metro_trend_magnitude": "significant", "national_p50": 90955.8, "national_trend_direction": "up", "national_trend_magnitude": "significant"}, {"role": "Lab Technician", "data_scope": "metro", "metro_p25": 38533.0, "metro_p50": 45760.0, "metro_p75": 47163.0, "metro_trend_direction": "down", "metro_trend_magnitude": "significant", "national_p50": 47402.2, "national_trend_direction": "down", "national_trend_magnitude": "moderate"}, {"role": "Regulatory Affairs Specialist", "data_scope": "metro", "metro_p25": 81225.5, "metro_p50": 119275.0, "metro_p75": 119456.25, "metro_trend_direction": "up", "metro_trend_magnitude": "significant", "national_p50": 104000.0, "national_trend_direction": "stable", "national_trend_magnitude": "stable"}, {"role": "Clinical Data Manager", "data_scope": "metro", "metro_p25": 102402.25, "metro_p50": 121796.0, "metro_p75": 142800.0, "metro_trend_direction": "down", "metro_trend_magnitude": "significant", "national_p50": 123031.0, "national_trend_direction": "down", "national_trend_magnitude": "moderate"}, {"role": "Biostatistician", "data_scope": "metro", "metro_p25": 88147.25, "metro_p50": 148588.0, "metro_p75": 167900.5, "metro_trend_direction": "down", "metro_trend_magnitude": "significant", "national_p50": 133322.0, "national_trend_direction": "up", "national_trend_magnitude": "moderate"}, {"role": "Validation Engineer", "data_scope": "metro", "metro_p25": 93211.0, "metro_p50": 108689.8, "metro_p75": 111066.0, "metro_trend_direction": "down", "metro_trend_magnitude": "moderate", "national_p50": 108377.0, "national_trend_direction": "up", "national_trend_magnitude": "moderate"}], "industry_snapshot": [], "citations": [], "methodology": "Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay.", "edition_label": "October 2026", "files": {"html": "durham-nc-msa/life-sciences/2026-09.html", "pdf": "durham-nc-msa/life-sciences/2026-09.pdf"}, "published_at": "2026-10-09T13:50:15.042037+00:00", "report_html_url": "https://reports.wagescape.com/archive/v1/editions/durham-nc-msa/life-sciences/2026-09.html", "report_pdf_url": "https://reports.wagescape.com/archive/v1/editions/durham-nc-msa/life-sciences/2026-09.pdf"}